We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Navient
NAVI
$880M
| $205K | ﹤0.01% |
+12,814
| New | +$224K |
|
1627
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $205K | ﹤0.01% |
500
-23,000
| -98% | -$9.18M |
|
1628
Cameco
CCJ
$41.1B
| $204K | ﹤0.01% |
7,814
-1,879
| -19% | -$49.7K |
|
1629
Reynolds Consumer Products
REYN
$5.5B
| $204K | ﹤0.01% |
7,414
-33,972
| -82% | -$960K |
|
1630
PUT
Constellation Brands
STZ
$22.4B
| $203K | ﹤0.01% |
900
-100
| -10% | -$22.3K |
|
1631
OGE Energy
OGE
$9.79B
| $203K | ﹤0.01% |
5,394
-65,454
| -92% | -$2.46M |
|
1632
Spectrum Brands
SPB
$2.11B
| $203K | ﹤0.01% |
3,067
-12,533
| -80% | -$791K |
|
1633
Summit Therapeutics
SMMT
$11.1B
| $203K | ﹤0.01% |
+116,022
| New | +$316K |
|
1634
UWM Holdings
UWMC
$661M
| $203K | ﹤0.01% |
+41,291
| New | +$181K |
|
1635
Trimble
TRMB
$13.8B
| $203K | ﹤0.01% |
3,867
-7,498
| -66% | -$400K |
|
1636
PUT
Flex
FLEX
$47.2B
| $202K | ﹤0.01% |
11,678
-20,037
| -63% | -$347K |
|
1637
Opko Health
OPK
$970M
| $202K | ﹤0.01% |
+138,600
| New | +$178K |
|
1638
PUT
Veeva Systems
VEEV
$34.2B
| $202K | ﹤0.01% |
+1,100
| New | +$188K |
|
1639
Aura Biosciences
AURA
$742M
| $202K | ﹤0.01% |
+21,772
| New | +$226K |
|
1640
Teck Resources
TECK
$32.1B
| $202K | ﹤0.01% |
+5,532
| New | +$220K |
|
1641
Orion
OEC
$376M
| $202K | ﹤0.01% |
+7,734
| New | +$175K |
|
1642
PUT
Kimberly-Clark
KMB
$36.9B
| $201K | ﹤0.01% |
1,500
| – | – |
|
1643
CALL
Blackrock
BLK
$176B
| $201K | ﹤0.01% |
300
| – | – |
|
|
SKYT
1644
DELISTED
SkyWater Technology
SKYT
| $200K | ﹤0.01% |
+17,583
| New | +$197K |
|
1645
Pangaea Logistics
PANL
$488M
| $200K | ﹤0.01% |
+34,055
| New | +$204K |
|
|
PR
1646
Permian Resources
PR
$17.2B
| $198K | ﹤0.01% |
+18,900
| New | +$193K |
|
1647
Helix Energy Solutions
HLX
$1.42B
| $198K | ﹤0.01% |
+25,600
| New | +$200K |
|
1648
AbCellera Biologics
ABCL
$1.86B
| $197K | ﹤0.01% |
+26,088
| New | +$237K |
|
1649
Acco Brands
ACCO
$404M
| $197K | ﹤0.01% |
+36,963
| New | +$211K |
|
1650
Maravai LifeSciences
MRVI
$953M
| $196K | ﹤0.01% |
13,991
-8,892
| -39% | -$128K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.